Being part of the Pistoia Alliance means our members don’t have to solve the same challenges alone. Together we solve them once and everyone moves faster.
The impact we deliver through collaboration extends across the biopharmaceutical industry, increasing the speed and efficiency of life sciences R&D.
Delivering impactful solutions addressing the biggest challenges in R&D.
Delivering Data-Driven Value
HOVER / TAP TO READ MOREWe released Version 1.0 of the Pharmaceutical CMC Process Ontology, a standardized, machine-readable representation of pharmaceutical Chemistry, Manufacturing and Controls processes.
Harnessing AI to Expedite R&D
HOVER / TAP TO READ MOREWe launched a new year-round Life Sciences AI Exchange program, a collaborative forum to share real-world implementation experience, benchmark progress and shape the future of AI adoption in the life sciences.
Sustainability-Driven R&D
HOVER / TAP TO READ MOREOur second Public-Private partnership with the FDA established a proof of concept for an SDTM-based data model for in vitro Novel Alternative Methods (NAMs) results using cardiac safety and hepatotoxicity data to validate a template for endpoints.
Accelerate Late Stage R&D
HOVER / TAP TO READ MOREWe published a Protocol for Social Media Listening Online (POMELO), a structured, step-by-step questionnaire from study setup to data analysis that helps organizations apply social media listening in a consistent, transparent, and scalable way.
Introducing the Pistoia Alliance Project Roadmap …
Explore the roadmapMaking Collaboration Real
This year was an exceptional year of progress. Our achievements were underpinned by the invaluable support of our Board of Directors and by our members’ unwavering commitment to collaborative innovation. We have made a significant impact by solving shared challenges together.
Bringing the industry together
We delivered collaboration through 25 active projects and communities, two world-class annual conferences and seven Informatics Forums. Our initiatives brought together 12,720 industry experts and professionals from across the world.
Accelerating and sustaining innovation
We strengthened our foundations with a seed fund to accelerate new ideas sparked by our members and made the sustainability of our solutions a top priority to ensure long-term value is delivered.
Trusted to deliver
Our membership represents 18 of the top 20 pharma companies by R&D spend and our engagement with regulators is stronger than ever. We signed agreements to collaborate with Allotrope Foundation and CDISC.
Looking Ahead
Tap or hover a card to read what this year meant to each of them.